T. Rowe Price Associates
AHPI

T. Rowe Price Associates’s Allied Healthcare Products AHPI Stock Holding History

T. Rowe Price Associates’s Portfolio AHPI Stock Details AHPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-24,700
Closed -$136K – 2742
2020
Q3 		$136K Sell
24,700
-4,200
-15% -$35.5K ﹤0.01% 2493
2020
Q2 		$340K Buy
28,900
+4,900
+20% +$58.3K ﹤0.01% 2206
2020
Q1 		$420K Buy
+24,000
New +$187K ﹤0.01% 2059

Other funds holding AHPI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HIS
Harvest Investment Services Oakbrook Terrace, Illinois $547M AUM 64.58% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

T. Rowe Price Associates's AHPI Position: Q4 2020 in Review

T. Rowe Price Associates sold out of Allied Healthcare Products (AHPI) in Q4 2020, closing a stake of 24,700 shares — an estimated $136K sold.

T. Rowe Price Associates first reported a position in AHPI in Q1 2020 and held it in 3 quarters. The position peaked at $420K in Q1 2020. 18 funds tracked by Wall St. Rank hold AHPI as of Q4 2020.

  • T. Rowe Price Associates reported no remaining Allied Healthcare Products position as of Q4 2020 after selling out during the quarter.
  • T. Rowe Price Associates sold 24,700 Allied Healthcare Products shares in Q4 2020, an estimated $136K.
  • T. Rowe Price Associates first reported a position in Allied Healthcare Products in Q1 2020 and held it in 3 quarters.
  • T. Rowe Price Associates's Allied Healthcare Products position peaked at $420K in Q1 2020.
  • 18 funds tracked by Wall St. Rank held Allied Healthcare Products as of Q4 2020.

Based on T. Rowe Price Associates's 13F filing for Q4 2020, filed 16 Feb 2021.